Before you sell to, join or invest in Mizar Therapeutics, Inc.
MentionFox check on Mizar Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/mizar-therapeutics-inc-form-d-25000001
Check Mizar Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Mizar Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Mizar Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-09.
Mizar Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 9, 2025. The filing reports $519K sold. Its industry group is Other Health Care. It names Joel Smith (Executive Officer, Director), Paul Maddox (Executive Officer, Director) (SEC Form D, June 9, 2025).
Is this your company?
Sell to companies like Mizar Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Mizar Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Mizar Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in Massachusetts, filed in June 2025, largest first.
Get an email when Mizar Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Mizar Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Mizar Therapeutics, Inc. →Get the full cited report on Mizar Therapeutics, Inc.
What the filing shows about Mizar Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Mizar Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Mizar Therapeutics, Inc.'s address as Po, Box 73, Woods Hole, MA 02543.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Mizar Therapeutics, Inc. See pricing
Mizar Therapeutics, Inc. is a registered filer with the SEC (CIK 2070986) and has filed since 2025-06-09. 1 filing is on record, the latest on 2025-06-09.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Mizar Therapeutics, Inc.'s Form D of 2025-06-09 names Joel Smith and Paul Maddox as its officers, directors or promoters.
Its new offerings report $519K sold across 1 offering, as its own filings state.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
Other than the payment of salaries and other compensation benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
Joel Smith is named as Executive Officer and Director on the Form D that Mizar Therapeutics, Inc. filed with the SEC on 9 June 2025, one of 2 people that filing names.
Paul Maddox is named as Executive Officer and Director on the Form D that Mizar Therapeutics, Inc. filed with the SEC on 9 June 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-06-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Mizar Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Mizar Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Mizar Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Mizar Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Mizar Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Mizar Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/mizar-therapeutics-inc-form-d-25000001